Stock Report

Download full stock data and analysis for free Last Updated: 17-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Smruthi Organics Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 540686

₹147.00

up-down-arrow ₹-1.95 (-1.31%)

As on 16-Oct-2026IST

Market cap

info icon

₹168 Cr

Revenue (TTM)

info icon

₹112 Cr

P/E Ratio

info icon

22.5

P/B Ratio

info icon

2.2

Div. Yield

info icon

1 %

Edit peer-selector-edit
Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Market cap (₹ Cr)
 168 31,674 26,307 26,224 25,017
Revenue (₹ Cr)
 112 3,564 9,205 1,462 1,936
Net Profit (₹ Cr)
 7.40 414.00 -371.81 387.35 288.22
Net Margin (%)
 6.64 11.23 -3.93 26.01 14.79
RoE (%)
 10.89 8.38 -3.85 25.18 29.77
Price to Earnings
 22.55 77.44 -- 67.90 86.80
Price-To-Book
 2.20 6.29 3.29 15.20 18.64

Income Statement (₹ Cr)

Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Operating Revenue arrow
112.28 3,564.00 9,205.28 1,461.80 1,935.80
Total Income arrow
112.34 3,686.00 9,449.59 1,489.25 1,948.58
Total Expenditure arrow
93.65 2,792.00 8,195.15 919.25 1,485.56
EBITDA arrow
18.62 772.00 1,010.13 542.56 450.24
Depreciation arrow
6.54 226.00 857.51 37.68 50.83
EBIT arrow
12.08 546.00 152.62 504.88 399.41
Interest arrow
1.54 217.00 342.73 3.77 40.84
Other Income arrow
0.06 122.00 244.31 27.45 12.78
Exceptional Items arrow
-0.46 12.00 -216.88 0.00 0.00
Profit before Tax arrow
10.15 463.00 -162.68 528.56 371.35
Provision for Tax arrow
2.68 49.00 209.13 141.21 83.14
Profit after Tax arrow
7.46 414.00 -371.81 387.35 288.22

Liabilities (₹ Cr)

Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Shareholder's Funds arrow
73.51 4,940.00 8,162.62 1,653.56 1,288.82
Minority Interest arrow
0.00 -5.00 0.00 -1.13 0.00
Non-Current Liabilities arrow
3.47 1,712.00 5,044.14 42.40 202.03
Current Liabilities arrow
26.56 1,622.00 4,758.28 230.82 835.87
Total Liabilities arrow
104.96 8,578.00 17,723.32 1,983.96 2,326.71

Assets (₹ Cr)

Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Non-Current Assets arrow
49.83 5,343.00 10,211.52 1,026.85 519.60
Current Assets arrow
52.68 2,606.00 7,191.66 881.27 1,681.81
Total Assets arrow
104.96 8,578.00 17,723.32 1,983.96 2,326.71
Total Debt* arrow
8.37 2,125.00 5,495.48 26.49 259.37
Net Current Assets arrow
26.12 984.00 2,433.38 650.46 845.94
Contingent Liabilities arrow
2.50 768.26 95.72 17.25 19.09

Cashflow (₹ Cr)

Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Cash From Operating Activities arrow
22.26 390.00 1,652.60 292.17 205.05
Cash Flow from Investing Activities arrow
-8.92 -241.00 -826.03 -265.94 -409.72
Cash from Financing Activities arrow
-12.07 -54.00 -38.98 4.10 283.07
Net Cash Inflow / Outflow arrow
1.27 95.00 787.59 30.33 78.39

Ratios

Profitability Ratios

 Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
ROCE (%) arrow
7.46 6.79 1.24 32.42 29.22
ROE (%) arrow
10.89 8.38 -3.85 25.18 29.77
ROA (%) arrow
6.93 4.94 -2.21 21.93 24.77
EBIT Margin (%) arrow
10.76 15.32 1.66 34.54 20.63
Net Margin (%) arrow
6.64 11.23 -3.93 26.01 14.79
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Revenue Growth (%) arrow
-4.52 18.37 0.78 40.90 46.65
EBIT Growth (%) arrow
88.11 252.26 -70.53 124.50 62.13
Net Profit Growth (%) arrow
116.63 377.85 -1,383.43 104.15 89.49
EPS Growth (%) arrow
128.08 1,001.33 -484.84 42.32 78.60
Book Value Growth (%) arrow
2.63 13.47 0.33 26.03 144.31

Valuation Ratios

 Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Price / Earnings arrow
21.41 79.49 -84.07 67.90 85.46
Price / Book Value arrow
2.20 6.29 3.29 15.20 18.64
Dividend Yield (%) arrow
1.02 0.00 0.00 0.08 0.10
EV/EBITDA arrow
9.36 42.92 30.14 47.97 55.37
Market Cap (₹ Cr) arrow
110.46 19,071.62 18,108.89 20,944.75 12,753.19

Solvency Ratios

 Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Debt to Equity arrow
0.04 0.31 0.53 0.02 0.11
Short term debt to equity ratio arrow
0.08 0.09 0.09 0.02 0.05
Current Ratio arrow
1.98 1.61 1.51 3.82 2.01
Quick Ratio arrow
0.92 1.06 0.87 2.82 1.14
Interest Coverage arrow
7.61 3.13 0.53 141.16 10.09

Operating Efficiency Ratios

 Smruthi Organics Wockhardt Piramal Pharma Acutaas Chemicals Rubicon Research
Debtors to sales (%) arrow
17.19 16.50 23.44 24.80 26.28
Asset Turnover arrow
1.04 0.43 0.55 0.83 1.66
Receivable days arrow
91.99 58.75 78.20 88.98 40.13
Inventory Days arrow
100.66 75.82 93.30 56.04 60.29
Payable days arrow
119.78 186.21 226.14 99.95 232.47
Cash Conversion Cycle arrow
72.87 -51.64 -54.64 45.07 -132.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...